Literature DB >> 31738948

In Vivo Bioluminescence Tomography Center of Mass-Guided Conformal Irradiation.

Zijian Deng1, Xiangkun Xu1, Tomas Garzon-Muvdi2, Yuanxuan Xia3, Eileen Kim3, Zineb Belcaid3, Andrew Luksik3, Russell Maxwell3, John Choi3, Hailun Wang1, Jingjing Yu4, Iulian Iordachita5, Michael Lim3, John W Wong1, Ken Kang-Hsin Wang6.   

Abstract

PURPOSE: The cone-beam computed tomography (CBCT)-guided small animal radiation research platform (SARRP) has provided unique opportunities to test radiobiologic hypotheses. However, CBCT is less adept to localize soft tissue targets growing in a low imaging contrast environment. Three-dimensional bioluminescence tomography (BLT) provides strong image contrast and thus offers an attractive solution. We introduced a novel and efficient BLT-guided conformal radiation therapy and demonstrated it in an orthotopic glioblastoma (GBM) model. METHODS AND MATERIALS: A multispectral BLT system was integrated with SARRP for radiation therapy (RT) guidance. GBM growth curve was first established by contrast CBCT/magnetic resonance imaging (MRI) to derive equivalent sphere as approximated gross target volume (aGTV). For BLT, mice were subject to multispectral bioluminescence imaging, followed by SARRP CBCT imaging and optical reconstruction. The CBCT image was acquired to generate anatomic mesh for the reconstruction and RT planning. To ensure high accuracy of the BLT-reconstructed center of mass (CoM) for target localization, we optimized the optical absorption coefficients μa by minimizing the distance between the CoMs of BLT reconstruction and contrast CBCT/MRI-delineated GBM volume. The aGTV combined with the uncertainties of BLT CoM localization and target volume determination was used to generate estimated target volume (ETV). For conformal irradiation procedure, the GBM was first localized by the predetermined ETV centered at BLT-reconstructed CoM, followed by SARRP radiation. The irradiation accuracy was qualitatively confirmed by pathologic staining.
RESULTS: Deviation between CoMs of BLT reconstruction and contrast CBCT/MRI-imaged GBM is approximately 1 mm. Our derived ETV centered at BLT-reconstructed CoM covers >95% of the tumor volume. Using the second-week GBM as an example, the ETV-based BLT-guided irradiation can cover 95.4% ± 4.7% tumor volume at prescribed dose. The pathologic staining demonstrated the BLT-guided irradiated area overlapped well with the GBM location.
CONCLUSIONS: The BLT-guided RT enables 3-dimensional conformal radiation for important orthotopic tumor models, which provides investigators a new preclinical research capability.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31738948      PMCID: PMC7007925          DOI: 10.1016/j.ijrobp.2019.11.003

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  43 in total

1.  Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research.

Authors:  Yidong Yang; Ken Kang-Hsin Wang; Sohrab Eslami; Iulian I Iordachita; Michael S Patterson; John W Wong
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

2.  Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images.

Authors:  John Virostko; Alvin C Powers; E Duco Jansen
Journal:  Appl Opt       Date:  2007-05-01       Impact factor: 1.980

3.  The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.

Authors:  Stephen Tuttle; Lauren Hertan; Natalie Daurio; Sarah Porter; Charanya Kaushick; Daqing Li; Shunsuke Myamoto; Alex Lin; Bert W O'Malley; Constantinos Koumenis
Journal:  Cancer Biol Ther       Date:  2012-05-01       Impact factor: 4.742

4.  Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor.

Authors:  Nikolay L Martirosyan; Daniel D Cavalcanti; Jennifer M Eschbacher; Peter M Delaney; Adrienne C Scheck; Mohammed G Abdelwahab; Peter Nakaji; Robert F Spetzler; Mark C Preul
Journal:  J Neurosurg       Date:  2011-09-16       Impact factor: 5.115

5.  Improved Overall Survival of Mice by Reducing Lung Side Effects After High-Precision Heart Irradiation Using a Small Animal Radiation Research Platform.

Authors:  Wolfgang Sievert; Stefan Stangl; Katja Steiger; Gabriele Multhoff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

6.  Image-guided small animal radiation research platform: calibration of treatment beam alignment.

Authors:  Mohammad Matinfar; Eric Ford; Iulian Iordachita; John Wong; Peter Kazanzides
Journal:  Phys Med Biol       Date:  2009-01-14       Impact factor: 3.609

7.  High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities.

Authors:  John Wong; Elwood Armour; Peter Kazanzides; Iulian Iordachita; Erik Tryggestad; Hua Deng; Mohammad Matinfar; Christopher Kennedy; Zejian Liu; Timothy Chan; Owen Gray; Frank Verhaegen; Todd McNutt; Eric Ford; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-01       Impact factor: 7.038

Review 8.  In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals.

Authors:  Dan M Close; Tingting Xu; Gary S Sayler; Steven Ripp
Journal:  Sensors (Basel)       Date:  2010-12-28       Impact factor: 3.576

9.  Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models.

Authors:  Grit S Herter-Sprie; Houari Korideck; Camilla L Christensen; Jan M Herter; Kevin Rhee; Ross I Berbeco; David G Bennett; Esra A Akbay; David Kozono; Raymond H Mak; G Mike Makrigiorgos; Alec C Kimmelman; Kwok-Kin Wong
Journal:  Nat Commun       Date:  2014-12-18       Impact factor: 14.919

10.  Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas.

Authors:  Lisa A Feldman; Marie-Sophie Fabre; Carole Grasso; Dana Reid; William C Broaddus; Gregory M Lanza; Bruce D Spiess; Joel R Garbow; Melanie J McConnell; Patries M Herst
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

View more
  5 in total

1.  Mobile bioluminescence tomography-guided system for pre-clinical radiotherapy research.

Authors:  Zijian Deng; Xiangkun Xu; Iulian Iordachita; Hamid Dehghani; Bin Zhang; John W Wong; Ken Kang-Hsin Wang
Journal:  Biomed Opt Express       Date:  2022-08-30       Impact factor: 3.562

2.  Quantitative molecular bioluminescence tomography.

Authors:  Alexander Bentley; Xiangkun Xu; Zijian Deng; Jonathan E Rowe; Ken Kang-Hsin Wang; Hamid Dehghani
Journal:  J Biomed Opt       Date:  2022-06       Impact factor: 3.758

3.  Quantitative Bioluminescence Tomography for In Vivo Volumetric-Guided Radiotherapy.

Authors:  Zijian Deng; Xiangkun Xu; Hamid Dehghani; Daniel M Sforza; Iulian Iordachita; Michael Lim; John W Wong; Ken Kang-Hsin Wang
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

5.  Quantitative Bioluminescence Tomography-Guided Conformal Irradiation for Preclinical Radiation Research.

Authors:  Xiangkun Xu; Zijian Deng; Hamid Dehghani; Iulian Iordachita; Michael Lim; John W Wong; Ken Kang-Hsin Wang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-16       Impact factor: 7.038

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.